How much does Wegovy cost: the pen, the pill, insured, cash, Medicare and compounded, in one table

Wegovy has six prices, and every article that gives you one of them is answering for someone else. Here are all six, with the condition attached to each and the source it came from, and then the routes that move you from an expensive row to a cheap one.

The table

Sources: NovoCare's pharmacy page for the cash prices,¹ Wegovy.com for the card,² Humana's Medicare explainer for the Bridge.³

With commercial insurance: $25, with a cap

Novo's savings card takes a covered Wegovy prescription down to "as little as $25 per month", but the same page carries the limit: "subject to a maximum savings of $100/month".² So the card removes up to $100 from whatever your plan's copay is. A $50 copay becomes $25 (the floor); a $200 copay becomes $100. Government plans are excluded from the card entirely.

Whether your plan covers Wegovy for weight is plan-specific and not guessable from the insurer's name. Here is what eight insurers say in their own documents:

Two doors worth knowing about. Wegovy is separately approved "to reduce the risk of major adverse cardiovascular events ... in adults with established CV disease and either obesity or overweight",⁴ and a plan that excludes weight-loss drugs may still cover it under that indication if you have heart disease. And a denied prior authorisation on a plan that lists Wegovy is appealable; the appeal guide covers which kind of refusal you got. The full order of operations is in getting a GLP-1 covered.

On Medicare: $50 through the Bridge

Ordinary Part D "doesn't cover weight loss medications when used only for weight loss".³ What changed on 1 July 2026 is the Medicare GLP-1 Bridge, which gives "eligible Part D plan members access to Foundayo, Wegovy (injection or tablet), or Zepbound (KwikPen) weight loss medications for a $50 copayment for each 30-day supply", running "through Dec. 31, 2027".³ It sits outside the normal Part D flow, so your plan's drug lookup may not show it; ask for it by name. Does Medicare cover GLP-1s has the mechanics.

Cash, the pen: $199, then $349

Novo's own pharmacy sells Wegovy direct. New patients "pay $199 for each month of 0.25 mg and 0.5 mg", the two starting doses, "for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg and $399 per month for Wegovy HD (semaglutide) injection 7.2 mg".¹

One useful feature of Novo's pen pricing: it is flat. 0.25 mg costs the same as 2.4 mg, so climbing the ladder costs nothing extra, which is not true of Zepbound's $299-to-$699 tiers; Zepbound vs Wegovy compares the two bills. The HD pen at $399 is the one exception, and Wegovy 7.2 mg covers who it is for.

Cash, the pill: $149 to $299

The Wegovy tablet is priced by strength: "$149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg", with a month being one bottle of 30.¹ The 25 mg is the label's maintenance dose, so the price you settle at is likely $299, still $50 under the pen. The Wegovy pill covers the trade against the injection.

Compounded: from $69

The cheapest semaglutide is compounded, the same molecule from a licensed pharmacy without FDA approval of the finished product, sold through telehealth programs. Today's prices, verified on each seller's page:

The gap to Novo's $349 is $280 a month, $3,360 a year, and what it buys and what FDA specifically worries about is in is compounded semaglutide safe.

A year, by route

The honest summary

Wegovy costs $25 if a commercial plan covers it, and $50 on Medicare through the Bridge. Paying Novo directly, it is $349 a month for the pen or $149 to $299 for the pill. The same molecule from a compounding pharmacy is $69 and up. Find out which row you are in before you price it. If you are in the cash rows, ask the two questions that move you: whether your plan has a weight benefit at all, and if you have heart disease, whether it covers Wegovy for that.